Shilpa Medicare Limited SHILPAMED.NS · Stock Open Shilpa Medicare Limited in new tab
Analyst price targets
Recent rating changes, newest first
Shilpa Medicare Limited Analysis (SHILPAMED.NS)
Is Shilpa Medicare Limited a good investment? Shilpa Medicare Limited (SHILPAMED.NS) is currently trading at 1025.30 INR. Market analysts have a consensus price target of 881.25 INR. This suggests the asset is currently trading above analyst expectations.
In terms of valuation, the stock trades at a P/E ratio of 68.96. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Shilpa Medicare Limited is expected to release its next earnings report on Nov. 6, 2026. The market consensus estimate for Forward EPS is 20.86.
For income investors, Shilpa Medicare Limited pays a dividend yield of 0.11%. With a payout ratio of 3%, the dividend appears sustainable.
Investor FAQ
Does Shilpa Medicare Limited pay a dividend?
Yes, it pays an annual dividend of 1.10 INR (0.11% yield).
What asset class is Shilpa Medicare Limited?
Shilpa Medicare Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 6, 2026. The company currently has a trailing EPS of 15.43.
Company Profile
Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzalutamide, fingolimod hydrochloride, gemcitabine HCl, ibrutinib, imatinib mesylate, irinotecan HCl trihydrate, lenalidomide, lenvatinib mesylate, letrozole, and melphalan HCL. It also provides nifedipine, oxaliplatin, pazopanib, pemetrexed disodium hemipentahydrate, pemetrexed dipotassium nonahydrate, pirfenidone, pomalidomide, sodium cholesteryl sulfate, sorafenib tosylate, sunitinib malate, temozolomide, teriflunomide, thalidomide, tranexamic and zoledronic acid, phenylephrine, citicholine, palbocicilib, nilotinib, nintedanib, praziquintol, carmustine, elthrombopag olamine, abacavir sulphate, tenofovir disproxyl fumarate API, tenofovir alfanamide, prucalopride succinate, and varenicline tartrate. In addition, the company offers GLP-1; HpAPI; intermediates; peptides; payloads and linkers; biopolymers; microbial and mammalian products; fermentation; small molecules; monoclonal antibodies and recombinant technology; and tablets, capsules, injectables, oral dissolving films, and transdermal patches. Further, it engages in wind power generation activities. The company serves wholesalers, distributors, doctors, pharmacy chain NGOs, hospitals, government institutions, and companies. The company was formerly known as Shilpa Antibiotics Ltd and changed its name to Shilpa Medicare Limited in February 2003. Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.60 INR
|
| Oct. 11, 2026 | 0.6000 |
| ▸2025 |
1.00 INR
|
| Oct. 23, 2025 | 1.0000 |
| ▸2022 |
1.10 INR
|
| Oct. 28, 2022 | 1.1000 |
| ▸2021 |
1.10 INR
|
| Oct. 7, 2021 | 1.1000 |
| ▸2020 |
1.10 INR
|
| March 21, 2020 | 1.1000 |
| ▸2019 |
1.00 INR
|
| Oct. 20, 2019 | 1.0000 |
| ▸2018 |
0.70 INR
|
| March 24, 2018 | 0.7000 |
| ▸2017 |
0.60 INR
|
| March 27, 2017 | 0.6000 |
| ▸2016 |
0.30 INR
|
| July 1, 2016 | 0.3000 |
| ▸2015 |
1.10 INR
|
| Oct. 28, 2015 | 1.1000 |
| ▸2014 |
1.00 INR
|
| Oct. 20, 2014 | 1.0000 |
| ▸2013 |
1.30 INR
|
| Aug. 19, 2013 | 1.3000 |
| ▸2012 |
0.90 INR
|
| Oct. 29, 2012 | 0.9000 |
| ▸2011 |
0.80 INR
|
| Oct. 22, 2011 | 0.8000 |
| ▸2010 |
0.70 INR
|
| Oct. 30, 2010 | 0.7000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Shilpa Medicare Limited | Oct 11, 2026 | Paid | 0.6 INR |
| Split Date | Split Ratio to 1 |
|---|---|
| July 16, 2013 | 1.5 |
| Nov. 6, 2015 | 2:1 |
| Oct. 3, 2025 | 2:1 |
Community Discussion